Drug-eluting bead transarterial chemoembolization as neoadjuvant therapy pre-liver transplantation for advanced-stage hepatocellular carcinoma

Figure 2 The patient was treated with drug-eluting bead transcatheter arterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus. A and B: Visible intrahepatic mass (A) and obvious enhancement of portal vein tumor thrombus (PVTT) III (B); C and D: After drug-eluting bead transcatheter arterial chemoembolization, the mass (C) and PVTT (D) showed extensive necrosis (C), and enhanced computed tomography showed a few enhanced lesions in the arterial phase: Modified response evaluation criteria in solid tumors efficacy was evaluated for partial response.